- Home
- EFOI vs NERV Comparison
EFOI vs NERV Comparison
Compare EFOI & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFOI
- NERV
- Stock Information
- Founded
- EFOI 1985
- NERV 2007
- Country
- EFOI United States
- NERV United States
- Employees
- EFOI N/A
- NERV N/A
- Industry
- EFOI Building Products
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- EFOI Consumer Discretionary
- NERV Health Care
- Exchange
- EFOI Nasdaq
- NERV Nasdaq
- Market Cap
- EFOI 13.4M
- NERV 12.0M
- IPO Year
- EFOI 1994
- NERV 2014
- Fundamental
- Price
- EFOI $2.95
- NERV $2.14
- Analyst Decision
- EFOI
- NERV Hold
- Analyst Count
- EFOI 0
- NERV 1
- Target Price
- EFOI N/A
- NERV $5.00
- AVG Volume (30 Days)
- EFOI 34.6K
- NERV 12.9K
- Earning Date
- EFOI 11-11-2025
- NERV 11-04-2025
- Dividend Yield
- EFOI N/A
- NERV N/A
- EPS Growth
- EFOI N/A
- NERV N/A
- EPS
- EFOI N/A
- NERV 1.48
- Revenue
- EFOI $4,233,000.00
- NERV N/A
- Revenue This Year
- EFOI N/A
- NERV N/A
- Revenue Next Year
- EFOI N/A
- NERV N/A
- P/E Ratio
- EFOI N/A
- NERV $1.46
- Revenue Growth
- EFOI N/A
- NERV N/A
- 52 Week Low
- EFOI $1.14
- NERV $1.15
- 52 Week High
- EFOI $3.56
- NERV $2.98
- Technical
- Relative Strength Index (RSI)
- EFOI 65.10
- NERV 47.70
- Support Level
- EFOI $2.42
- NERV $2.06
- Resistance Level
- EFOI $3.56
- NERV $2.25
- Average True Range (ATR)
- EFOI 0.20
- NERV 0.12
- MACD
- EFOI 0.05
- NERV -0.03
- Stochastic Oscillator
- EFOI 49.17
- NERV 20.60
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.